NEW YORK (GenomeWeb) – Biocept announced today that it has partnered with Providence St. Joseph Health, Southern California, and its affiliates Saint John's Health Center and the John Wayne Cancer Institute, to evaluate usage of cerebral spinal fluid (CSF) in liquid biopsy testing for metastatic cancer.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.